Literature DB >> 6481115

The effect of lactulose on psychomotor performance tests in alcoholic cirrhotics without overt hepatic encephalopathy.

C J McClain, T J Potter, J P Kromhout, L Zieve.   

Abstract

Thirty-two alcoholic cirrhotics without clinical evidence of encephalopathy were randomized to lactulose or sucrose treatment in order to evaluate the effects of chronic lactulose therapy on five psychomotor performance tests. Statistically significant improvement was seen in three of the five tests in the lactulose-treated group, while no significant improvement in any test was noted in the sucrose group. However, because of the limited extent of improvement in the lactulose treated group, problems with medication intolerance, and lack of improvement in complex psychosocial behavior, the impact of chronic lactulose therapy on mental function in cirrhotics without overt encephalopathy appears to be limited.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6481115

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  5 in total

1.  Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.

Authors:  R K Dhiman; M S Sawhney; Y K Chawla; G Das; S Ram; J B Dilawari
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

2.  Memory impairment in patients with cirrhosis.

Authors:  Funda Bahceci; Bulent Yildirim; Melih Karincaoglu; Ibrahim Dogan; Birsen Sipahi
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

Review 3.  Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Lise Lotte Gluud; Hendrik Vilstrup; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2016-05-06

4.  Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats.

Authors:  Lin Jia; Mei-Hua Zhang
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

Review 5.  Minimal hepatic encephalopathy.

Authors:  Radha K Dhiman; Yogesh K Chawla
Journal:  Indian J Gastroenterol       Date:  2009 Jan-Feb
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.